Conflict noted between African scientists

Mar 08, 2007

A conflict between scientists working with the human immunodeficiency virus and those working with tuberculosis is being reported in Africa.

The controversy stems from the fact TB is the leading cause of death among those infected with HIV and, in some African countries, about 60 percent of those with TB are also HIV-positive.

Although there are serious drug interactions between HIV and TB medicines, physicians are also finding a deadly new syndrome called IRIS, which results when those with TB are put on HIV medicines.

Yet, observers note, the two communities continue to work separately, diagnosing and treating one disease without taking the other into account. Adding to the problem is the fact TB researchers receive less than 10 percent of the funding given to HIV-AIDS scientists annually.

And since existing drugs and vaccines for tuberculosis were developed decades ago, the TB infrastructure needs to be updated. But without needed funding, researchers are struggling to find new drugs and vaccines.

The controversy is detailed in a special report appearing in this month's issue of the New York-published journal Nature Medicine.

Copyright 2007 by United Press International

Explore further: Allergan to cut 1,500 employees in restructuring (Update)

add to favorites email to friend print save as pdf

Related Stories

Research may yield new ways to treat antibiotic-resistant TB

Jun 27, 2014

Scientists in the United States and India have successfully modified the precursor to one of the drugs used to treat tuberculosis, an important first step toward new drugs that can transcend antibiotic resistance issues that ...

New technique tracks proteins in single HIV particle

May 05, 2014

An interdisciplinary team of scientists from KU Leuven in Belgium has developed a new technique to examine how proteins interact with each other at the level of a single HIV viral particle. The technique ...

Recommended for you

British Lords hold ten-hour debate on assisted dying

Jul 19, 2014

Members of Britain's unelected House of Lords spent almost ten hours on Friday discussing whether to legalise assisted dying, in an often emotional debate putting the question back on the agenda, if not on the statute books.

AbbVie, Shire agree on $55B combination

Jul 18, 2014

The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home.

Safety problems at US germ labs acknowledged

Jul 16, 2014

(AP)—The director of the U.S. Centers for Disease Control and Prevention acknowledged Wednesday that systemic safety problems have for years plagued federal public health laboratories that handle dangerous ...

User comments : 0